HLB Pharmaceutical Market Cap

HLB Pharmaceutical has a market cap or net worth of 207.26 billion as of March 9, 2026. Its market cap has decreased by -41.43% in one year.

Market Cap

207.26B

Enterprise Value

197.61B

Revenue

36.10B

Ranking

n/a

PE Ratio

438.51

Stock Price

14,760.00

Market Cap Chart

Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 207.26B, an increase of 145.92%. That is a compound annual growth rate of 9.21%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	212.04B	-5.86%
Dec 30, 2025	225.24B	-33.44%
Dec 30, 2024	338.42B	58.45%
Dec 28, 2023	213.58B	43.49%
Dec 29, 2022	148.85B	-21.48%
Dec 30, 2021	189.57B	-21.05%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jeil Pharmaceutical Co.,Ltd	210.56B
Samjin Pharmaceuticals	222.85B
Samil Pharmaceutical Co.,Ltd	223.34B
JW Lifescience	200.22B
Daewon Pharmaceutical	229.34B
AptaBio Therapeutics	193.84B
Chong Kun Dang Holdings	233.27B
Ilyang Pharmaceutical Co.,Ltd	233.92B

Market Cap Rankings